Bad Blood by John Carreyrou
ISBN
9781509868070
Date Released
Binding
Paperback
Pages
320
Dimensions
154 x 234 x 27mm

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.

For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos' articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.

In Bad Blood John Carreyrou tells the story of Theranos, and encourages us to consider the possible repercussions of our blind faith in a small group of brilliant individuals.
32.99





Enter your Postcode or Suburb to view availability and delivery times.

Loyalty Reward Rebate
  1. $1.65*
  2. $2.31*
  3. $3.30*
  4. $3.30*
  * Rebate calculated before redemption of credit. See Terms for more information.

Other Titles by John Carreyrou

Description
Information
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.

For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos' articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.

In Bad Blood John Carreyrou tells the story of Theranos, and encourages us to consider the possible repercussions of our blind faith in a small group of brilliant individuals.

Now to be adapted into a film, with Jennifer Lawrence to star.
Attachments area
ISBN:
9781509868070
Publication Date:
29 / 05 / 2018
Pages:
320
Dimensions:
154 x 234 x 27mm

You might also like


RRP refers to the Recommended Retail Price as set out by the original publisher at time of release.
The RRP set by overseas publishers may vary to those set by local publishers due to exchange rates and shipping costs.
Due to our competitive pricing, we may have not sold all products at their original RRP.